These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 30021187)
21. Temozolomide stability in extemporaneously compounded oral suspensions. Trissel LA; Zhang Y; Koontz SE Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320 [TBL] [Abstract][Full Text] [Related]
22. Stability of zonisamide in extemporaneously compounded oral suspensions. Abobo CV; Wei B; Liang D Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126 [TBL] [Abstract][Full Text] [Related]
23. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C. Nahata MC; Morosco RS; Trowbridge JM Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513 [TBL] [Abstract][Full Text] [Related]
24. Stability of norfloxacin in an extemporaneously prepared oral liquid. Johnson CE; Price J; Hession JM Am J Health Syst Pharm; 2001 Apr; 58(7):577-9. PubMed ID: 11296605 [TBL] [Abstract][Full Text] [Related]
25. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions. Zhang YP; Trissel LA; Fox JL Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892 [TBL] [Abstract][Full Text] [Related]
26. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions. Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577 [TBL] [Abstract][Full Text] [Related]
27. Stability of ursodiol in an extemporaneously compounded oral liquid. Johnson CE; Nesbitt J Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836 [TBL] [Abstract][Full Text] [Related]
28. Stability of sumatriptan succinate in extemporaneously prepared oral liquids. Fish DN; Beall HD; Goodwin SD; Fox JL Am J Health Syst Pharm; 1997 Jul; 54(14):1619-22. PubMed ID: 9248606 [TBL] [Abstract][Full Text] [Related]
29. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids. Allen LV; Erickson MA Am J Health Syst Pharm; 1998 Sep; 55(17):1804-9. PubMed ID: 9775343 [TBL] [Abstract][Full Text] [Related]
30. Stability of ciprofloxacin in an extemporaneous oral liquid dosage form. Johnson CE; Wong DV; Hoppe HL; Bhatt-Mehta V Int J Pharm Compd; 1998; 2(4):314-7. PubMed ID: 23989641 [TBL] [Abstract][Full Text] [Related]
31. Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children. Pramann LA; Davidow LW; van Haandel L; Funk RS Int J Pharm Compd; 2016; 20(3):257-261. PubMed ID: 28333668 [TBL] [Abstract][Full Text] [Related]
32. Stability of levofloxacin in an extemporaneously compounded oral liquid. VandenBussche HL; Johnson CE; Fontana EM; Meram JM Am J Health Syst Pharm; 1999 Nov; 56(22):2316-8. PubMed ID: 10582824 [TBL] [Abstract][Full Text] [Related]
33. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids. Allen LV; Erickson MA Am J Health Syst Pharm; 1998 Sep; 55(18):1915-20. PubMed ID: 9784772 [TBL] [Abstract][Full Text] [Related]
34. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids. Allen LV; Erickson MA Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895 [TBL] [Abstract][Full Text] [Related]
35. Stability of ganciclovir in extemporaneously compounded oral liquids. Anaizi NH; Swenson CF; Dentinger PJ Am J Health Syst Pharm; 1999 Sep; 56(17):1738-41. PubMed ID: 10512505 [TBL] [Abstract][Full Text] [Related]
36. Formulation and stability of an extemporaneously compounded oral solution of chlorpromazine HCl. Prohotsky DL; Juba KM; Zhao F J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):367-70. PubMed ID: 25338106 [TBL] [Abstract][Full Text] [Related]
37. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C. Nahata MC; Morosco RS; Hipple TF Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509 [TBL] [Abstract][Full Text] [Related]